Rice Hall James & Associates, LLC Rocket Pharmaceuticals, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.69 Billion
- Q3 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 92,142 shares of RCKT stock, worth $959,198. This represents 0.1% of its overall portfolio holdings.
Number of Shares
92,142
Previous 75,423
22.17%
Holding current value
$959,198
Previous $1.62 Million
4.81%
% of portfolio
0.1%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
210Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$184 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$117 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$64.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$57.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$46.8 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $788M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...